What Happened?
Cambridge, MA-based Cygnal-Therapeutics Appointed Pearl Huang as Chief Executive Officer
Date of management change: January 15, 2001
Cambridge, MA-based Cygnal-Therapeutics Appointed Pearl Huang as Chief Executive Officer
Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platform™, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.
Pearl Huang is Chief Executive Officer at Cygnal Therapeutics. Previously, Pearl held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Butler Jill, K Jenny, Ponzio Christine, Miller Angie, Gossett Nancy, Turner David, Durbin Meredith, Gaytan Alejandra, Kape Brian, Sebel Mandy, Kaslow Andrew
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.